SLD ASX · Health Care

Saluda Medical, Inc

Announcements, last 12 months: 67
Price sensitive, last 12 months: 13
Followed on InvestorPA: Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
23 Oct 2026, 12:48 PM	Appendix 4G and Corporate Governance Statement
23 Oct 2026, 12:38 PM	Annual Report to Stockholders
23 Oct 2026, 12:34 PM	Notice of Annual Stockholders Meeting and CDI Voting Form
21 Oct 2026, 8:25 AM	Voluntary Field Action for Certain Evoke System Devices
14 Oct 2026, 1:02 PM	Notification of cessation of securities - SLD
14 Oct 2026, 12:59 PM	Notification regarding unquoted securities - SLD
6 Oct 2026, 8:21 AM	Expands Access with Full US Commercial Release of CAP24
24 Sep 2026, 10:45 AM	Initial Director's Interest Notice
24 Sep 2026, 10:37 AM	Director Appointment/Resignation
14 Sep 2026, 9:11 AM	Final Director's Interest Notice - B Regan

Sign in to see all SLD announcements.

Guidance history

28 Aug 2026	FY27 revenue guidance of $113-$122M, gross margin of 50%-52%, and adjusted EBITDA of ($101)-($95)M
28 Aug 2026	FY27 revenue growth: 25%-35%, gross margin: 50%-52%, adjusted EBITDA loss: $101M-$95M
29 Jul 2026	FY26 full-year revenue of US$90.2 million, exceeding guidance of US$87.0 million

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow SLD to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.